![Jason Keyes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Keyes
Directeur Financier/CFO chez
BLOSSOMHILL THERAPEUTICS, INC.
Fortune : 289 513 $ au 31/07/2026
Profil
Mr. Jason A. Keyes is a Chief Financial Officer & Executive Vice President at Blossomhill Therapeutics, Inc. and an Independent Director at Actuate Therapeutics, Inc. He is on the Board of Directors at Actuate Therapeutics, Inc. Mr. Keyes was previously employed as an Independent Director by Sesen Bio, Inc., a Chief Financial Officer by Equillium, Inc., a Chief Financial Officer & Executive Vice President by Orexigen Therapeutics, Inc., a Senior Director-Finance by Amylin Pharmaceuticals, Inc., and a Head-Finance & Strategy by Amgen, Inc. He received his undergraduate degree from Stanford University, a graduate degree from Stanford University and an MBA from UCLA Anderson School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EQUILLIUM, INC. 0,2 % | 14/02/2025 | 126 633 ( 0,2 % ) | 278 593 $ | 31/07/2026 |
| 10/08/2026 | 700 ( 0 % ) | 10 920 $ | 31/07/2026 | |
| 21/05/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Postes actifs de Jason Keyes
| Sociétés | Poste | Début |
|---|---|---|
| ACTUATE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 12/08/2024 |
| BLOSSOMHILL THERAPEUTICS, INC. | Directeur Financier/CFO | 01/05/2025 |
Anciens postes connus de Jason Keyes
| Sociétés | Poste | Fin |
|---|---|---|
| EQUILLIUM, INC. | Directeur Financier/CFO | 25/04/2025 |
| CARISMA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 07/03/2023 |
| OREXIGEN THERAPEUTICS, INC. | Directeur Financier/CFO | 23/02/2018 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Directeur Financier/CFO | 01/01/2013 |
| AMGEN INC. | Corporate Officer/Principal | - |
Formation de Jason Keyes
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
61
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on the treatment of obesity | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics to treat eye diseases | Health Technology |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actuate Therapeutics, Inc.
 Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel therapeutics which target cancers and neurodegenerative diseases | Health Technology |
Equillium, Inc.
 Equillium, Inc. BiotechnologyHealth Technology Engages in the development of products for severe immune-inflammatory disorders | Health Technology |
Blossomhill Therapeutics, Inc.
 Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for oncology and autoimmune diseases | Health Technology |
